Access cutting-edge multiple sclerosis treatment through this clinical trial at a research site in Maitland. Study-provided care at no cost to qualified participants.
Access multiple sclerosis specialists in Maitland at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple sclerosis treatment provided free
The goal of this clinical trial is to learn if drug CYB704, a proposed biosimilar to Ocrevus, works to treat multiple sclerosis in the same way as the reference product Ocrevus(R). The main questions it aims to answer are: * Is CYB704 distributed in the body in the same way as the reference product (demonstration of pharmacokinetic (PK) similarity)? * Does have CYB704 the same treatment effect and side effects as the reference product? Researchers will compare CYB704 to a Ocrevus (Ocrevus-US
Sponsor: Sandoz
Check if you qualify for this multiple sclerosis clinical trial in Maitland, FL
If you're searching for multiple sclerosis treatment options in Maitland, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Maitland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple sclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.